Literature DB >> 9640407

Serum follistatin concentrations are increased in patients with septicaemia.

U Michel1, Y Shintani, R Nau.   

Abstract

OBJECTIVE: Follistatin (FS) is the specific binding protein of activin, a growth and differentiation factor of many cell types. Both factors have almost ubiquitous tissue distributions. In vitro, FS is secreted by vascular endothelial cells and this can be stimulated by bacterial compounds. For this reason, serum FS levels were examined in patients with septicaemia. PATIENTS: Five male and four female patients of different age with various forms of septicaemia and different clinical outcome. MEASUREMENTS: Serum concentrations of FS, C-reactive protein (CRP) and blood leucocyte counts were determined repeatedly in all nine patients; samples from age- and sex-matched healthy volunteers served as controls.
RESULTS: The median of the maximum FS concentrations of septicaemic patients was threefold higher than in healthy controls (P = 0.008). The highest increase observed was approximately 40 times normal. Serum FS levels in patients with septicaemia showed large variations between individuals. Serum FS levels parallelled those of CRP but were not correlated to the leucocyte counts.
CONCLUSION: Serum follistatin concentrations in humans are elevated during septicaemia and appear to parallel serum C-reactive protein levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640407     DOI: 10.1046/j.1365-2265.1998.00484.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Hepatokines-a novel group of exercise factors.

Authors:  Cora Weigert; Miriam Hoene; Peter Plomgaard
Journal:  Pflugers Arch       Date:  2018-10-18       Impact factor: 3.657

2.  Imbalance of Amniotic Fluid Activin-A and Follistatin in Intraamniotic Infection, Inflammation, and Preterm Birth.

Authors:  John T Hardy; Irina A Buhimschi; Megan E McCarthy; Guomao Zhao; Christine A Laky; Lydia L Shook; Catalin S Buhimschi
Journal:  J Clin Endocrinol Metab       Date:  2016-05-09       Impact factor: 5.958

3.  Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Laura F Newell; Todd E DeFor; Corey Cutler; Michael R Verneris; Bruce R Blazar; Jeff S Miller; Joseph H Antin; Alan Howard; Juan Wu; Margaret L MacMillan; Angela Panoskaltsis-Mortari; Daniel J Weisdorf; Shernan G Holtan
Journal:  Biol Blood Marrow Transplant       Date:  2019-11-10       Impact factor: 5.742

4.  Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism.

Authors:  Fen-Yu Tseng; Yen-Ting Chen; Yu-Chao Chi; Pei-Lung Chen; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

5.  Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.

Authors:  L M Turcotte; T E DeFor; L F Newell; C S Cutler; M R Verneris; J Wu; A Howard; M L MacMillan; J H Antin; G M Vercellotti; Ane Slungaard; B R Blazar; D J Weisdorf; A Panoskaltsis-Mortari; S G Holtan
Journal:  Bone Marrow Transplant       Date:  2017-10-23       Impact factor: 5.483

6.  Androgen-Influenced Polarization of Activin A-Producing Macrophages Accompanies Post-pyelonephritic Renal Scarring.

Authors:  Teri N Hreha; Christina A Collins; Allyssa L Daugherty; Jessie M Griffith; Keith A Hruska; David A Hunstad
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

7.  The Regulation of Circulating Hepatokines by Fructose Ingestion in Humans.

Authors:  Michael M Richter; Peter Plomgaard
Journal:  J Endocr Soc       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.